No abstract available
MeSH terms
-
AIDS-Related Opportunistic Infections / complications*
-
Abscess / etiology*
-
Abscess / surgery
-
Adult
-
Anti-HIV Agents / administration & dosage
-
Anti-HIV Agents / therapeutic use
-
Antiretroviral Therapy, Highly Active
-
Antitubercular Agents / therapeutic use
-
Axilla
-
Clarithromycin / administration & dosage
-
Clarithromycin / therapeutic use
-
Darunavir
-
Dideoxynucleosides / administration & dosage
-
Dideoxynucleosides / therapeutic use
-
Enfuvirtide
-
Ethambutol / administration & dosage
-
Ethambutol / therapeutic use
-
HIV Envelope Protein gp41 / administration & dosage
-
HIV Envelope Protein gp41 / therapeutic use
-
HIV-1*
-
Humans
-
Immune Reconstitution Inflammatory Syndrome / etiology*
-
Isoniazid / administration & dosage
-
Isoniazid / therapeutic use
-
Lamivudine / administration & dosage
-
Lamivudine / therapeutic use
-
Lymph Node Excision
-
Lymphadenitis / etiology*
-
Lymphadenitis / surgery
-
Male
-
Mycobacterium avium-intracellulare Infection / complications*
-
Mycobacterium avium-intracellulare Infection / surgery
-
Peptide Fragments / administration & dosage
-
Peptide Fragments / therapeutic use
-
Pyrazinamide / administration & dosage
-
Pyrazinamide / therapeutic use
-
Rifampin / administration & dosage
-
Rifampin / therapeutic use
-
Ritonavir / administration & dosage
-
Ritonavir / therapeutic use
-
Streptomycin / administration & dosage
-
Streptomycin / therapeutic use
-
Sulfonamides / administration & dosage
-
Sulfonamides / therapeutic use
Substances
-
Anti-HIV Agents
-
Antitubercular Agents
-
Dideoxynucleosides
-
HIV Envelope Protein gp41
-
Peptide Fragments
-
Sulfonamides
-
Enfuvirtide
-
Pyrazinamide
-
Lamivudine
-
Ethambutol
-
Clarithromycin
-
Ritonavir
-
Isoniazid
-
Rifampin
-
abacavir
-
Streptomycin
-
Darunavir